Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Dexamethasone sodium phosphate by AVM Biotechnology for Natural Killer Cell Lymphomas: Likelihood of Approval
Dexamethasone sodium phosphate is under clinical development by AVM Biotechnology and currently in Phase II for Natural Killer Cell Lymphomas....
Dexamethasone sodium phosphate by AVM Biotechnology for Metastatic Pancreatic Cancer: Likelihood of Approval
Dexamethasone sodium phosphate is under clinical development by AVM Biotechnology and currently in Phase II for Metastatic Pancreatic Cancer. According...
Dexamethasone sodium phosphate by AVM Biotechnology for Unspecified B-Cell Lymphomas: Likelihood of Approval
Dexamethasone sodium phosphate is under clinical development by AVM Biotechnology and currently in Phase II for Unspecified B-Cell Lymphomas. According...
Dexamethasone sodium phosphate by Quince Therapeutics for Ataxia-Telangiectasia (Louis-Bar Syndrome): Likelihood of Approval
Dexamethasone sodium phosphate is under clinical development by Quince Therapeutics and currently in Phase III for Ataxia-Telangiectasia (Louis-Bar Syndrome). According...
Dexamethasone sodium phosphate by Scilex Holding for Back Pain: Likelihood of Approval
Dexamethasone sodium phosphate is under clinical development by Scilex Holding and currently in Phase III for Back Pain. According to...
Dexamethasone sodium phosphate by Quince Therapeutics for Duchenne Muscular Dystrophy: Likelihood of Approval
Dexamethasone sodium phosphate is under clinical development by Quince Therapeutics and currently in Phase I for Duchenne Muscular Dystrophy. According...
Dexamethasone sodium phosphate by AVM Biotechnology for Primary Mediastinal B-Cell Lymphoma: Likelihood of Approval
Dexamethasone sodium phosphate is under clinical development by AVM Biotechnology and currently in Phase II for Primary Mediastinal B-Cell Lymphoma....
Dexamethasone sodium phosphate by AVM Biotechnology for Burkitt Lymphoma: Likelihood of Approval
Dexamethasone sodium phosphate is under clinical development by AVM Biotechnology and currently in Phase II for Burkitt Lymphoma. According to...
Dexamethasone sodium phosphate by AVM Biotechnology for Mantle Cell Lymphoma: Likelihood of Approval
Dexamethasone sodium phosphate is under clinical development by AVM Biotechnology and currently in Phase II for Mantle Cell Lymphoma. According...
Dexamethasone sodium phosphate by AVM Biotechnology for Diffuse Large B-Cell Lymphoma: Likelihood of Approval
Dexamethasone sodium phosphate is under clinical development by AVM Biotechnology and currently in Phase II for Diffuse Large B-Cell Lymphoma....